Article summary
This open-label pilot study (n=16) evaluated MDMA-assisted brief cognitive-behavioural conjoint therapy in eight US military veterans with PTSD and their partners. PTSD symptoms and relationship functioning improved substantially after treatment, although relationship gains partly declined at follow-up; no serious adverse events were reported.
Continue to the original publication for the complete article.